immunate 250 iu fviii/190 iu vwf powder and solvent for solution for injection
takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 250 iu von willebrand factor, human 190 iu - antihemorrhagics
immunate 500 iu fviii/375 iu vwf powder and solvent for solution for injection
takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 500 iu von willebrand factor, human 375 iu - antihemorrhagics
immunate 1000 iu fviii/750 iu vwf powder and solvent for solution for injection
takeda manufacturing austria ag industriestrasse 67, a-1221, vienna, austria - factor viii, human, von willebrand - powder and solvent for solution for injection - factor viii, human 1000 iu von willebrand factor, human 750 iu - antihemorrhagics
haemate p 1200 iu vwf/500 iu fviii 1 200 iu - 500 iu inj./inf. sol. (pwdr. + solv.) i.v. vial
csl behring gmbh - human factor von willebrand 1200 iu; human coagulation factor viii 500 iu - powder and solvent for solution for injection/infusion - 1200 iu - 500 iu - human coagulation factor viii 500 iu; factor von willebrand 1200 iu - von willebrand factor and coagulation factor viii in combination
haemate p 2400 iu vwf/1000 iu fviii 2 400 iu - 1 000 iu inj./inf. sol. (pwdr. + solv.) i.v. vial
csl behring gmbh - human factor von willebrand 2400 iu; human coagulation factor viii 1000 iu - powder and solvent for solution for injection/infusion - 2400 iu - 1000 iu - human coagulation factor viii 1000 iu; factor von willebrand 2400 iu - von willebrand factor and coagulation factor viii in combination
alphanate (antihemophilic factor/von willebrand factor complex- human kit
grifols usa, llc - human coagulation factor viii/von willebrand factor complex (unii: 5t6b772r4q) (human coagulation factor viii/von willebrand factor complex - unii:5t6b772r4q) - human coagulation factor viii/von willebrand factor complex 250 [iu] in 5 ml - alphanate, (antihemophilic factor/von willebrand factor complex [human]), is indicated for: - control and prevention of bleeding episodes and perioperative management in adult and pediatric patients with factor viii (fviii) deficiency due to hemophilia a. - surgical and/or invasive procedures in adult and pediatric patients with von willebrand disease (vwd) in whom desmopressin (ddavp) is either ineffective or contraindicated. it is not indicated for patients with severe vwd (type 3) undergoing major surgery. alphanate is contraindicated in patients who have manifested life-threatening immediate hypersensitivity reactions, including anaphylaxis, to the product or its components [see adverse reactions (6) ]. pregnancy category c. animal reproduction studies have not been conducted with alphanate. it is also not known whether alphanate can cause fetal harm when administered to a pregnant woman or affect reproductive capacity. alphanate should be given to a pregnant woman only if clearly needed. no human o
humate-p (antihemophilic factor/von willebrand factor complex- human kit
csl behring gmbh - human coagulation factor viii/von willebrand factor complex (unii: 5t6b772r4q) (human coagulation factor viii/von willebrand factor complex - unii:5t6b772r4q) - human coagulation factor viii/von willebrand factor complex 80 [iu] in 1 ml - humate-p, antihemophilic factor/von willebrand factor complex (human), is indicated for treatment and prevention of bleeding in adults with hemophilia a (classical hemophilia). humate-p is also indicated in adult and pediatric patients with von willebrand disease (vwd) for: controlled clinical trials to evaluate the safety and efficacy of prophylactic dosing with humate-p to prevent spontaneous bleeding have not been conducted in vwd subjects [see clinical studies (14)]. humate-p is contraindicated in individuals who have had an anaphylactic or severe systemic reaction to antihemophilic factor or von willebrand factor preparations. animal reproduction studies have not been conducted with humate-p. it is also not known whether humate-p can cause fetal harm when administered to a pregnant woman or can affect reproduction capacity. humate-p should be given to a pregnant woman only if clearly needed. it is not known whether humate-p can cause harm to the mother or the fetus when administered during labor and deli
biostate human coagulation factor viii 500iu / von willebrand factor 1200iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 500 iu; von willebrand factor, quantity: 1200 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
biostate human coagulation factor viii 250iu / von willebrand factor 600iu powder for injection vial with diluent vial
csl behring australia pty ltd - factor viii, quantity: 250 iu; von willebrand factor, quantity: 600 iu - injection, diluent for - excipient ingredients: - the prophylaxis and treatment of non-surgical and surgical bleeding in patients with von willebrand disease when desmopressin (ddavp) treatment is ineffective or contraindicated. the prophylaxis and treatment of non-surgical and surgical bleeding associated with factor viii deficiency due to haemophilia a.
dried factor viii fraction type 8y 250unit powder and solvent for solution for injection vials
bio products laboratory ltd - von willebrand factor; factor viii - powder and solvent for solution for injection - 500unit ; 250unit